{"id":"NCT01998906","sponsor":"Hoffmann-La Roche","briefTitle":"A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer","officialTitle":"A Randomized, Open-label Study of the Effect of Paclitaxel, Doxorubicin, and CMF Neoadjuvant Chemotherapy, With and Without Herceptin, on Tumor Response in Women With HER2-positive Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-05","primaryCompletion":"2012-07","completion":"2012-07","firstPosted":"2013-12-02","resultsPosted":"2014-10-28","lastUpdate":"2014-10-28"},"enrollment":330,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Trastuzumab","otherNames":["Herceptin"]},{"type":"DRUG","name":"Doxorubicin","otherNames":[]},{"type":"DRUG","name":"Paclitaxel","otherNames":[]},{"type":"DRUG","name":"CMF","otherNames":[]}],"arms":[{"label":"HER-2+ Trastuzumab, Doxorubicin/Paclitaxel/CMF","type":"EXPERIMENTAL"},{"label":"HER-2+ Doxorubicin/Paclitaxel/CMF","type":"ACTIVE_COMPARATOR"},{"label":"HER-2- Doxorubicin/Paclitaxel/CMF","type":"ACTIVE_COMPARATOR"}],"summary":"This study will assess the efficacy and safety of adding Herceptin to a paclitaxel-containing regimen followed by cyclophosphamide/methotrexate/fluorouracil (CMF) chemotherapy in women with locally advanced breast cancer and HER2/c-erbB-2 gene amplification. In a parallel observational study patients with HER2-negative disease will receive the same chemotherapy without Herceptin.","primaryOutcome":{"measure":"Event-Free Survival (EFS) - Percentage of Participants With an Event","timeFrame":"Baseline (BL), Presurgery: Day 1 (Cycles 1-7) and Days 1 and 8 (Cycles 8-10); Postsurgery: Day 1 (Cycles 1-17); every 6 months up to 60 months after last dose of study drug; yearly thereafter","effectByArm":[{"arm":"HER2+ TC","deltaMin":40,"sd":null},{"arm":"HER2+ C","deltaMin":50.9,"sd":null},{"arm":"HER2- C","deltaMin":42.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":36,"countries":["Austria","Germany","Italy","Portugal","Russia","Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":115},"commonTop":["Alopecia","Nausea","Vomiting","Asthenia","Stomatitis"]}}